Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2012

4257 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

Movement disorders after stroke in adults: a review.

Bansil S, Prakash N, Kaye J, Wrigley S, Manata C, Stevens-Haas C, Kurlan R.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-42-195-1. doi: 10.7916/D86W98TB.

0

0

0

PUBMED

Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert.

Santos-García D, de la Fuente-Fernández R, Valldeoriola F, Palasí A, Carrillo F, Grande M, Mir P, De Fabregues O, Casanova J.

J Neurol. 2012 Aug;259(8):1668-72. doi: 10.1007/s00415-011-6396-z. Review.

0

0

0

PUBMED

Dissecting the effects of disease and treatment on impulsivity in Parkinson's disease.

Simioni AC, Dagher A, Fellows LK.

J Int Neuropsychol Soc. 2012 Nov;18(6):942-51. doi: 10.1017/S135561771200094X.

0

0

0

PUBMED

Cannabinoids: novel medicines for the treatment of Huntington's disease.

Sagredo O, Pazos MR, Valdeolivas S, Fernandez-Ruiz J.

Recent Pat CNS Drug Discov. 2012 Apr 1;7(1):41-8. Review.

0

0

0

PUBMED

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).

Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R.

Mult Scler. 2012 Feb;18(2):219-28. doi: 10.1177/1352458511419700.

0

0

0

PUBMED

Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.

Golla RM, Li M, Shen Y, Ji M, Yan Y, Fu K, Greiner TC, McKeithan TW, Chan WC.

Hematol Oncol. 2012 Dec;30(4):175-9. doi: 10.1002/hon.1020.

0

0

0

PUBMED

Inactivation of the parietal reach region causes optic ataxia, impairing reaches but not saccades.

Hwang EJ, Hauschild M, Wilke M, Andersen RA.

Neuron. 2012 Dec 6;76(5):1021-9. doi: 10.1016/j.neuron.2012.10.030.

0

0

0

PUBMED

A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease.

Miller JP, Yates BE, Al-Ramahi I, Berman AE, Sanhueza M, Kim E, de Haro M, DeGiacomo F, Torcassi C, Holcomb J, Gafni J, Mooney SD, Botas J, Ellerby LM, Hughes RE.

PLoS Genet. 2012;8(11):e1003042. doi: 10.1371/journal.pgen.1003042.

0

0

0

PUBMED

Toward a network model of dystonia.

Hendrix CM, Vitek JL.

Ann N Y Acad Sci. 2012 Aug;1265:46-55. doi: 10.1111/j.1749-6632.2012.06692.x.

0

0

0

PUBMED

Population pharmacokinetic-pharmacodynamic analysis of istradefylline in patients with Parkinson disease.

Knebel W, Rao N, Uchimura T, Mori A, Fisher J, Gastonguay MR, Chaikin P.

J Clin Pharmacol. 2012 Oct;52(10):1468-81.

0

0

0

PUBMED

Sexual behavior, body image, and partnership in chronic illness: a comparison of Huntington's disease and multiple sclerosis.

Reininghaus E, Reininghaus B, Fitz W, Hecht K, Bonelli RM.

J Nerv Ment Dis. 2012 Aug;200(8):716-20. doi: 10.1097/NMD.0b013e318261410f.

0

0

0

PUBMED

Effectiveness of clozapine in treating severe tardive dystonia and associated pyosis.

Pinninti NR, Desantis MJ, Adityanjee A.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):E5-6. doi: 10.1176/appi.neuropsych.11010020. No abstract available.

0

0

0

PUBMED

Cognition, coping, and outcome in Parkinson's disease.

Hurt CS, Landau S, Burn DJ, Hindle JV, Samuel M, Wilson K, Brown RG; PROMS-PD Study Group..

Int Psychogeriatr. 2012 Oct;24(10):1656-63. doi: 10.1017/S1041610212000749.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy